The Benefits of a Multidisciplinary Approach to Managing Prostate Cancer

Author(s):

Joseph F. Renzulli MD, FACS ,Mitchell Cornet, MPP, MHSA

Key Takeaways

Androgen deprivation therapy remains fundamental, but resistance necessitates additional treatments like androgen receptor signaling inhibitors.
Chemotherapy, especially docetaxel, is combined with ADT for improved outcomes in specific patient groups.
Radiopharmaceuticals and immunotherapy are emerging, providing targeted and systemic therapeutic benefits.
Genomic profiling enables personalized treatment plans, enhancing efficacy and minimizing adverse effects.

Panelists discuss how the landscape of treatment options for advanced prostate cancer has evolved, highlighting the importance of understanding current therapies to optimize patient outcomes.

EP: 1.When and Why To Get Screened for Prostate Cancer

EP: 2.Understanding Prostate-Specific Antigen (PSA) Testing

Now Viewing

EP: 3.The Benefits of a Multidisciplinary Approach to Managing Prostate Cancer

EP: 4.Understanding Diagnosis and Partnering With Your Care Team

EP: 5.Understanding Your Treatment Options for Advanced Prostate

EP: 6.Navigating Post-Surgery Recovery

EP: 7.Prostate Cancer and Intimacy

EP: 8.Support and Advocacy Groups

EP: 9.Treatment Options for Recurrent Prostate Cancer

EP: 10.Promoting Inclusivity and Bridging Gaps in Prostate Cancer Care

EP: 11.Proactive Health and Holistic Approaches to Prostate Cancer Care

EP: 12.Closing Reflections and the Importance of Early Detection

Video content above is prompted by the following:

Can you provide an overview of the current treatment options for advanced prostate cancer and how they’ve evolved?